JP2011500537A5 - - Google Patents

Download PDF

Info

Publication number
JP2011500537A5
JP2011500537A5 JP2010528414A JP2010528414A JP2011500537A5 JP 2011500537 A5 JP2011500537 A5 JP 2011500537A5 JP 2010528414 A JP2010528414 A JP 2010528414A JP 2010528414 A JP2010528414 A JP 2010528414A JP 2011500537 A5 JP2011500537 A5 JP 2011500537A5
Authority
JP
Japan
Prior art keywords
methyl
pyrrolidinyl
chlorophenyl
alkyl
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2010528414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011500537A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/063642 external-priority patent/WO2009047336A1/en
Publication of JP2011500537A publication Critical patent/JP2011500537A/ja
Publication of JP2011500537A5 publication Critical patent/JP2011500537A5/ja
Ceased legal-status Critical Current

Links

JP2010528414A 2007-10-11 2008-10-10 H1受容体アンタゴニストとしてのフタラジンおよびピリド[3,4−d]ピリダジン化合物 Ceased JP2011500537A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97910507P 2007-10-11 2007-10-11
PCT/EP2008/063642 WO2009047336A1 (en) 2007-10-11 2008-10-10 Phthalazine and pyrido [3,4-d] pyridaz ine compounds as h1 receptor antagonists

Publications (2)

Publication Number Publication Date
JP2011500537A JP2011500537A (ja) 2011-01-06
JP2011500537A5 true JP2011500537A5 (enExample) 2011-12-01

Family

ID=40104668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010528414A Ceased JP2011500537A (ja) 2007-10-11 2008-10-10 H1受容体アンタゴニストとしてのフタラジンおよびピリド[3,4−d]ピリダジン化合物

Country Status (6)

Country Link
US (1) US20100216799A1 (enExample)
EP (1) EP2215082B1 (enExample)
JP (1) JP2011500537A (enExample)
AT (1) ATE525370T1 (enExample)
ES (1) ES2369320T3 (enExample)
WO (1) WO2009047336A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006115221A1 (ja) * 2005-04-21 2006-11-02 Nippon Shinyaku Co., Ltd. フタラジノン誘導体及びその医薬
UA97506C2 (xx) * 2006-12-28 2012-02-27 Эбботт Лаборетриз Інгібітори полі(adp-рибозо)полімерази$ингибиторы поли(adp-рибозо)полимеразы
CA2685219C (en) * 2007-05-04 2012-06-19 Amgen Inc. Diazaquinolones that inhibit prolyl hydroxylase activity
CN115135315B (zh) 2019-12-20 2024-11-26 米拉蒂治疗股份有限公司 Sos1抑制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813384A (en) * 1972-01-17 1974-05-28 Asta Werke Ag Chem Fab Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE3575135D1 (de) * 1984-09-14 1990-02-08 Asta Pharma Ag Substituierte benzylphthalazinon-derivate.
DE3634942A1 (de) * 1985-11-11 1987-05-14 Asta Werke Ag Chem Fab Neue 4-benzyl-1-(2h)-phthalazinon-derivate
ATE60598T1 (de) * 1985-11-11 1991-02-15 Asta Pharma Ag 4-benzyl-1-(2h)-phthalazinon-derivate.
EP0289939A1 (de) * 1987-05-08 1988-11-09 ASTA Pharma AG Neue 4-Benzyl-1-(2H)-phthalazinon-Derivate mit einem Aminosäurerest
CZ199593A3 (en) * 1992-10-02 1994-04-13 Asta Medica Ag Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr)
US6180629B1 (en) * 1998-08-14 2001-01-30 Cell Pathways, Inc. [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia
ES2209337T3 (es) * 1998-08-14 2004-06-16 Pfizer Inc. Agentes antitromboticos.
US20030073692A1 (en) * 2001-08-07 2003-04-17 Pharmacia & Upjohn S.P.A. Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
CA2519220A1 (en) * 2003-03-18 2004-09-30 Merck & Co., Inc. Amino cyclobutylamide modulators of chemokine receptor activity
JP4735261B2 (ja) * 2003-06-27 2011-07-27 Msd株式会社 ヘテロアリールオキシ含窒素飽和ヘテロ環誘導体
ES2341813T3 (es) * 2006-12-20 2010-06-28 Glaxo Group Limited 4-bencil-1 (2h)-ftalazinonas como antagonistas del receptor h1.

Similar Documents

Publication Publication Date Title
JP2009536620A5 (enExample)
RU2342383C2 (ru) ПРОИЗВОДНЫЕ ИМИДАЗОЛ-4-ИЛЭТИНИЛПИРИДИНА, СПОСОБ ИХ ПОЛУЧЕНИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ В КАЧЕСТВЕ АНКСИОЛИТИКА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И СПОСОБ ЛЕЧЕНИЯ НАРУШЕНИЙ, ОПОСРЕДУЕМЫХ РЕЦЕПТОРОМ mGLuR5
SI2961736T1 (en) Histone demethylase inhibitors
JP2016538313A5 (enExample)
JP2010509356A5 (enExample)
JP2014528433A5 (enExample)
RU2009148673A (ru) Производные пиразинона и их применение для лечения легочных заболеваний
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2017504642A5 (enExample)
JP2005536475A5 (enExample)
JP2014502979A5 (enExample)
JP2015531773A (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP2007505922A5 (enExample)
JP2014511891A5 (enExample)
JP2008504266A5 (enExample)
RU2014152790A (ru) Пирролопиразоновые ингибиторы танкиразы
JP2007502265A5 (enExample)
RU2013138569A (ru) Антагонисты рецептора минералокортикоидов
JP2018515525A5 (enExample)
JP2010513393A5 (enExample)
RU2008120850A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
JP2007520440A5 (enExample)
JP2013533253A5 (enExample)
JP2017517538A5 (enExample)
JP2004525183A5 (enExample)